G1 THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.49 USD | +1.13% |
|
+12.53% | +47.21% |
| 05-01 | Transcript : G1 Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
| 05-01 | Earnings Flash (GTHX) G1 THERAPEUTICS Reports Q1 Revenue $14.5M, vs. Street Est of $15.1M | MT |
Chart calendar G1 Therapeutics, Inc.
4bf873436d8c6.TGPdH8SYQV1H9jZL4oMvGBVkhDgORXO1w134WHJJJP4.Bg2_KfT5Jml1zmdy1uUeQSQ75RU-KwbFjGy1YC0ASKYhK7p09Po3Cx-8WQ~10780b391828448d0d493d226bca7a6b
Upcoming events on G1 Therapeutics, Inc.
Past events on G1 Therapeutics, Inc.
| 01/05/2024 13:30 | Q1 2024 Earnings Call |
| 01/05/2024 11:30 | Q1 2024 Earnings Release |
| 11/04/2024 13:45 | Needham Healthcare Conference |
| 06/03/2024 14:10 | TD Cowen Health Care Conference - Panel |
| 28/02/2024 13:30 | Q4 2023 Earnings Call |
| 28/02/2024 11:30 | Q4 2023 Earnings Release |
| 18/01/2024 16:30 | B. Riley Securities Oncology Conference |
| 10/01/2024 21:30 | JPMorgan Healthcare Conference |
| 06/12/2023 23:00 | San Antonio Breast Cancer Symposium - Presentation No - PO2-06-12 |
| 01/11/2023 12:30 | Q3 2023 Earnings Call |
| 01/11/2023 10:30 | Q3 2023 Earnings Release |
| 28/10/2023 12:00 | American Society of Clinical Oncology Quality Care Symposium - Abstract 531 |
| 28/10/2023 12:00 | American Society of Clinical Oncology Quality Care Symposium - Abstract 289 |
| 28/10/2023 12:00 | American Society of Clinical Oncology Quality Care Symposium - Abstract 527 |
| 27/10/2023 16:30 | American Society of Clinical Oncology Quality Care Symposium - Abstract 364 |
| 12/09/2023 14:30 | H.C. Wainwright Global Investment Conference |
| 08/08/2023 | Wedbush PacGrow Healthcare Conference |
| 06/08/2023 | BTIG Virtual Biotechnology Conference |
| 02/08/2023 13:30 | Q2 2023 Earnings Call |
| 02/08/2023 11:30 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 45,3 32,8 37.96% | 31,5 31,4 0.17% | 51,3 50,9 0.81% | 82,5 80,6 2.35% | 69,4 |
|
EBITDA Million USD | Released Forecast Spread | -129 -130 1.01% | -95,9 -105 8.24% | -142 -148 3.74% | -136 -141 3.8% | -39,0 -45,0 13.3% | -36,0 |
|
EBIT Million USD | Released Forecast Spread | -129 -129 0.3% | -96,5 -107 9.46% | -142 -149 4.07% | -136 -141 3.68% | -39,5 -44,7 11.58% | -28,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -122 -123 0.78% | -97,8 -106 7.99% | -147 -152 2.85% | -146 -152 3.82% | -44,9 -50,0 10.3% | -33,9 |
|
Net income Million USD | Released Forecast Spread | -122 -123 0.73% | -99,3 -108 7.9% | -148 -152 2.56% | -148 -153 3.37% | -48,0 -52,2 8.06% | -33,9 |
|
EPS USD | Released Forecast Spread | -3,27 -3,29 0.52% | -2,62 -2,85 8.04% | -3,54 -3,63 2.56% | -3,38 -3,50 3.53% | -0,93 -0,97 4.12% | -0,59 |
| Announcement Date | 26/02/20 | 24/02/21 | 23/02/22 | 01/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,90 6,12 12.74% | 10,6 8,87 19.16% | 23,6 23,3 1.3% | 10,3 9,82 4.35% | 12,9 11,2 15.6% | 42,4 28,9 46.65% | 12,3 14,2 -13.55% | 14,9 13,0 14.17% | 14,5 15,1 -3.97% | 16,0 | 17,5 | 21,2 | 18,9 | 20,4 |
|
EBITDA Million USD | Released Forecast Spread | -46,7 -41,5 -12.35% | -36,8 -42,3 12.87% | -21,4 -31,0 30.94% | -30,8 -36,5 15.75% | -25,6 -29,5 13.17% | 11,6 -13,0 189.58% | -16,2 -19,0 14.52% | -8,81 -15,0 41.3% | -8,93 -9,00 0.8% | -8,47 | -7,76 | -9,00 | -4,40 | -2,30 |
|
EBIT Million USD | Released Forecast Spread | -46,8 -41,3 -13.33% | -37,0 -42,6 13.23% | -21,5 -26,2 17.77% | -30,9 -36,1 14.48% | -25,7 -32,1 19.86% | 11,5 -10,2 212.37% | -16,4 -17,0 3.78% | -8,93 -14,2 37.23% | -9,05 -9,45 4.25% | -8,15 | -7,59 | -9,01 | -4,92 | -2,10 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -49,2 -41,9 -17.3% | -39,4 -43,7 9.69% | -24,1 -27,0 10.91% | -33,2 -38,9 14.79% | -27,6 -33,4 17.37% | 10,0 -11,2 189.34% | -17,3 -18,0 3.93% | -9,98 -15,1 33.92% | -10,2 -10,4 1.47% | -8,88 | -8,30 | -7,92 | -5,42 | -2,60 |
|
Net income Million USD | Released Forecast Spread | -49,2 -41,9 -17.3% | -39,4 -43,7 9.69% | -25,3 -27,0 6.4% | -33,6 -38,9 13.56% | -27,6 -33,4 17.37% | 8,71 -11,2 177.68% | -18,2 -18,0 -1.1% | -10,9 -15,1 27.95% | -10,2 -10,4 1.47% | -8,88 | -8,30 | -7,92 | -5,41 | -2,60 |
|
EPS USD | Released Forecast Spread | -1,15 -0,98 -17.32% | -0,92 -1,02 9.72% | -0,59 -0,63 6.65% | -0,73 -0,84 13.45% | -0,53 -0,64 17.18% | 0,14 -0,22 164.08% | -0,35 -0,33 -6.08% | -0,21 -0,28 23.91% | -0,20 -0,20 -0.97% | -0,17 | -0,14 | -0,12 | -0,11 | -0,09 |
| Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 01/03/23 | 03/05/23 | 02/08/23 | 01/11/23 | 28/02/24 | 01/05/24 | - | - | - | - | - |
More events
Past sector events for G1 Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GTHX Stock
- Calendar G1 Therapeutics, Inc.
